Beta coronaviruses and human endocrine system: new data (review of literature)

Klin Lab Diagn. 2022 Mar 25;67(3):140-146. doi: 10.51620/0869-2084-2022-67-3-140-146.

Abstract

A new dangerous respiratory disease COVID-19 was first reported in China in December 2019, the pathogen SARS-Coronavirus 2 (SARS-CoV-2), belonging to the beta coronavirus genus, which, in addition to SARS-CoV-2, includes SARS-CoV-1 and MERS-CoV. The genome of SARS-CoV-2 is almost 80% similar to SARS-CoV-1 and 50% to MERS-CoV. The mechanisms of infection of SARS-CoV-1 and SARS-CoV-2 are also similar and occur through the binding of the virus to the type 2 angiotensin-converting enzyme protein (ACE2), which is widely represented in the human body with predominant expression in endocrine tissues. In this connection, SARS-CoV-1 and SARS-CoV-2 affect the organs of the endocrine system, causing damage and hormonal changes that affect the prognosis of the course of COVID-19. This literature review is devoted to the analysis of changes in the organs of the endocrine system that occur during infection with SARS-CoV-1 and SARS-CoV-2, as well as the potential effect of hormones on susceptibility to SARS-CoV-2.

Keywords: COVID-19; SARS-CoV-1; SARS-CoV-2; adrenal glands; endocrine system; hypothalamus; pituitary gland; thyroid gland.

Publication types

  • Review

MeSH terms

  • Angiotensin-Converting Enzyme 2* / genetics
  • COVID-19*
  • Endocrine System
  • Humans
  • SARS-CoV-2

Substances

  • Angiotensin-Converting Enzyme 2